BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $872 | -64.3% | 131 | 0.0% | 0.00% | – |
| Q1 2023 | $2,444 | +81366.7% | 131 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.8% | 131 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 131 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 131 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 131 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 131 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 131 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |